Sofwave AI Stock Analysis
Want to see IL:SOFW full AI Analyst Report?
Sofwave (SOFW) AI Stock Analysis
Sofwave
(TASE:SOFW)
The score is driven primarily by improved financial performance (recent shift to profitability, strong cash generation, and very low leverage) and supportive technical momentum (price above major moving averages with positive MACD). The main offset is valuation risk (P/E 33.95 with no dividend yield provided), which raises sensitivity to any slowdown after a relatively recent turnaround.
Sofwave (SOFW) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 1.27B
- Dividend Yield
- ―
- Average Volume (3M)
- 96.87K
- Price to Earnings (P/E)
- 31.5
- Beta (1Y)
- 0.62
- Revenue Growth
- 25.84%
- EPS Growth
- 1717.73%
- Country
- Israel
- Employees
- 151
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
Sofwave Business Overview & Revenue Model
Company Description
Founded in 2015, Sofwave Medical Ltd. is an Israeli company dedicated to developing cutting-edge ultrasound technology. This technology is employed for the non-invasive treatment of fine lines and wrinkles, with the company's reach extending to physi...
Sofwave Financial Statement Overview
Summary
Strong fundamental turnaround: revenue scaled from 35.6M (2022) to 94.9M (2025) and 111.9M (TTM), gross margins remain high (~74%–76%), and profitability improved to ~11.8% operating margin and ~10.7% net margin (TTM). Balance sheet leverage is very low (debt ~1.25M vs equity ~42.6M), and cash flow flipped to strong positive (OCF ~15.7M; FCF ~14.9M in TTM). Key risk is the recency of the turnaround after losses through 2024 and mixed cash conversion signals (coverage below 1).
Income Statement
78PositiveBalance Sheet
86Very PositiveCash Flow
80Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.91M | 94.86M | 59.65M | 50.31M | 35.63M | 21.84M |
| Gross Profit | 85.01M | 70.27M | 45.34M | 37.48M | 26.33M | 16.24M |
| EBITDA | 15.70M | 9.39M | -2.19M | -6.61M | -17.55M | -6.43M |
| Net Income | 12.02M | 5.94M | -4.55M | -8.28M | -19.53M | -6.83M |
Balance Sheet | ||||||
| Total Assets | 65.99M | 55.78M | 43.03M | 43.54M | 46.08M | 60.77M |
| Cash, Cash Equivalents and Short-Term Investments | 30.88M | 35.28M | 21.62M | 24.42M | 32.01M | 46.22M |
| Total Debt | 1.25M | 1.12M | 1.40M | 1.33M | 1.92M | 2.37M |
| Total Liabilities | 23.37M | 23.06M | 18.50M | 17.19M | 13.74M | 14.07M |
| Stockholders Equity | 42.62M | 32.72M | 24.53M | 26.34M | 32.34M | 46.70M |
Cash Flow | ||||||
| Free Cash Flow | 14.92M | 14.51M | -2.67M | -6.71M | -11.14M | -2.92M |
| Operating Cash Flow | 15.69M | 15.08M | -2.40M | -6.31M | -10.69M | -2.10M |
| Investing Cash Flow | -10.74M | -1.15M | 254.00K | 409.00K | -260.00K | -982.00K |
| Financing Cash Flow | -77.98K | -469.79K | -620.00K | -1.72M | -1.35M | 46.64M |
Sofwave Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:SOFW, the sentiment is Negative. The current price of 3496.00 is below the 20-day moving average (MA) of 3610.70, above the 50-day MA of 3451.30, and below the 200-day MA of 3829.88, indicating a neutral trend. The MACD of 61.73 indicates Positive momentum. The RSI at 47.15 is Neutral, neither overbought nor oversold. The STOCH value of 30.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:SOFW.
Sofwave Peers Comparison
Overall Rating
- IL:SOFW75Outperform
IL:BWAY70Outperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:SOFW | Sofwave Medical Ltd. | 3496.00 | 576.00 | 19.73% | |
| IL:BWAY | Brainsway | 3250.00 | 705.00 | 27.70% | |
| IL:ILX | ILEX Medical Ltd. | 4788.00 | -1958.53 | -29.03% | |
| IL:ALMD | Allmed Solutions Ltd. | 30.20 | -1.40 | -4.43% | |
| IL:EPIT | EPITOMEE MEDICAL LTD | 266.00 | -482.80 | -64.48% | |
| IL:PLSM | Pulsenmore | 488.10 | -2379.65 | -82.98% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 10, 2026